👋
Is this profile yours? Take control to keep your details current, set fees, and respond to reviews.
This page is aggregated from public sources.
Claim this profile →
✓ Verified
Trust score 98/100
Accepting new patients
Dr
Dr David Bloomfield
Oncology
English
6,993+
Patients seen
3
Years in practice
12
Publications
1
Languages spoken
About
Dr David Bloomfield is a specialist in the management of breast and urological cancer. His time in a Clinical Research Fellowship in Canada has had a big influence on his medical interest, where he had the opportunity to study clinical Epidemiology at the University of Toronto, concentrating on the effectiveness of treatments and developing clinical research trials.
Dr. Bloomfield's specialist training was at University College Hospital London and the Royal Marsden. He was appointed to a Consultant Clinical Oncologist post in Sussex in 1998. In 2001 Dr Bloomfield set up the Sussex Cancer Research Network. He has led Oncology as Head of Department since 2004 and then appointed to Principal Lead Clinician for Cancer Services at BSUH in 2006.
Dr Bloomfield has a longstanding interest in teaching; The MSc in Oncology at the Institute of Cancer Research that he set up as joint Course Director in 2006 has gone from strength to strength. It currently educates about half of the UK oncology specialists. He has also been keen to introduce oncology to the medical students at Brighton & Sussex Medical School early in their clinical studies; with a strong interest in improving the curriculum wherever possible.
Dr Bloomfield's main interest is spending time with his family. They share a range of interests in music, outdoor pursuits such as hill walking, rock climbing and horse riding.
Diseases, Medical Tests and Treatments
• Biological therapy
• Chemotherapy
• Complex radiotherapy
• Hormone therapy
• Urological oncology
• Breast oncology
• Testicular cancer
Dr. Bloomfield's specialist training was at University College Hospital London and the Royal Marsden. He was appointed to a Consultant Clinical Oncologist post in Sussex in 1998. In 2001 Dr Bloomfield set up the Sussex Cancer Research Network. He has led Oncology as Head of Department since 2004 and then appointed to Principal Lead Clinician for Cancer Services at BSUH in 2006.
Dr Bloomfield has a longstanding interest in teaching; The MSc in Oncology at the Institute of Cancer Research that he set up as joint Course Director in 2006 has gone from strength to strength. It currently educates about half of the UK oncology specialists. He has also been keen to introduce oncology to the medical students at Brighton & Sussex Medical School early in their clinical studies; with a strong interest in improving the curriculum wherever possible.
Dr Bloomfield's main interest is spending time with his family. They share a range of interests in music, outdoor pursuits such as hill walking, rock climbing and horse riding.
Diseases, Medical Tests and Treatments
• Biological therapy
• Chemotherapy
• Complex radiotherapy
• Hormone therapy
• Urological oncology
• Breast oncology
• Testicular cancer
“Evidence-based care tailored to each patient — taking the time to explain options and shared decisions.”
— Dr David Bloomfield
Education & training
-
2013–2019 MD · Medicine and Surgery
-
2019–2023 Residency · Oncology
-
2023–2024 Fellowship · Subspecialty training
Career & appointments
-
2023-09–2024-08 Junior consultant
Licenses & insurance
Medical licenses
GB — Organización Médica Colegial de España (OMC)
Board certifications
European Board of Oncology
Malpractice insurance:
HDI Global · 4,000,000 EUR coverage
· No claims on file
Procedures performed
| Procedure | Code | Lifetime count |
|---|---|---|
| GP consultation | 99213 | 1,090 |
| Annual physical exam | 99395 | 508 |
| Vaccination administration | 90471 | 1,420 |
| Minor procedure (skin) | 17110 | 2,347 |
Services & pricing
| Service | Duration | Modality | Price |
|---|---|---|---|
| New patient consultation (60m) | 60 min | in_clinic|telemed | 180.00 EUR |
| Follow-up consultation (30m) | 30 min | in_clinic|telemed|phone | 90.00 EUR |
| Vaccination administration | 30 min | in_clinic | 630.00 EUR |
| Minor procedure (skin) | 120 min | in_clinic | 720.00 EUR |
Office, team & in practice
Videos
Research & publications
h-index: 13 · i10: 6
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.1622/euroclin.2025.0 · PMID: 31956131 · cited by 90
-
European registry analysis of Oncology outcomes
DOI: 10.5845/euroclin.2024.1 · PMID: 30768510 · cited by 136
-
Outcomes of Oncology in adults — a multi-centre cohort
DOI: 10.3630/euroclin.2023.2 · PMID: 36786751 · cited by 166
Invited talks
- Practical updates in Oncology European Annual Congress (Oncology) · Vienna · 2024 · invited
- Single-centre experience in Oncology National Society Meeting · · 2023 · oral abstract
Awards & memberships
Awards
- 🏆 Top-rated Oncology — · EuroClinics Patient Choice · 2025 · regional
- 🏆 Excellence in Patient Care · National Society · 2024 · national
- 🏆 Young Investigator Award · European Society · 2023 · international
Society memberships
- WONCA Europe — Family Doctors — Member · since 2024
- national college of family doctors — Member · since 2024
- European Union of Medical Specialists (UEMS) — Member · since 2024
Patient reviews
- Bedside Manner
- 5.00
- Knowledge
- 5.00
- Wait Time
- 4.75
- Staff Friendliness
- 5.00
- Ease Of Appointment
- 4.90
- Value For Money
- 4.92
- Would Recommend Pct
- 99
-
★ 5 verified visit
“Very thorough first visit — explained every step. Booking was easy and the staff were welcoming.”
-
★ 5 verified visit
“Took time to listen and reviewed all my previous results. I would absolutely recommend.”
-
★ 4 verified visit
“Professional and knowledgeable. Wait on the day was a bit long, otherwise excellent.”
Articles by this doctor
- Patient education Patient guide to Oncology
- Awareness When should you see a oncology?
For international patients
- Coordinator
- Patient liaison · dr.david.bloomfield@euroclinics.example
- Accepted intl insurance
- Allianz Worldwide · AXA Global · BUPA Global · Cigna Global
